ALECTINIB | ALECTINIB | ATC L01ED03
ANTINEOPLASTIC TREATMENT OF ANAPLASTIC LYMPHOMA KINASE (ALK)-POSITIVE, METASTATIC NON-SMALL CELL LUNG CANCER TYROSINE KINASE INHIBITOR (ALK AND RET) | ORAL | Cmax 1.38 MICROMOLAR Tmax 4 HOUR F 37 PERCENT VD 4016 LITER PPB 99 PERCENT Cl 81.9 LITER / HOUR HT 33 HOUR | ALK KINASE RET KINASE PDB 3AOX (X-RAY CRYSTAL STRUCTURE OF HUMAN ANAPLASTIC LYMPHOMA KINASE IN COMPLEX WITH CH5424802) LIGAND CODE = EMH (link to the list of PDB complexes) Download experimental 3D coordinates of EMH with added hydrogens | ALK tyrosine kinase receptor UNIPROT Q9UM73 ALK -- Proto-oncogene tyrosine-protein kinase receptor Ret UNIPROT P07949 RET more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |